Castleark Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-78,180
| Closed | -$9.09M | – | 342 |
|
|
2022
Q1 | $9.09M | Buy |
78,180
+4,380
| +6% | +$509K | 0.39% | 53 |
|
|
2021
Q4 | $11.1M | Buy |
73,800
+42,810
| +138% | +$6.44M | 0.41% | 59 |
|
|
2021
Q3 | $3.7M | Buy |
+30,990
| New | +$3.7M | 0.14% | 153 |
|
|
2020
Q4 | – | Sell |
-131,850
| Closed | -$15M | – | 365 |
|
|
2020
Q3 | $15M | Buy |
131,850
+30,065
| +30% | +$3.41M | 0.59% | 42 |
|
|
2020
Q2 | $10.1M | Buy |
101,785
+14,370
| +16% | +$1.42M | 0.44% | 51 |
|
|
2020
Q1 | $5.63M | Buy |
+87,415
| New | +$5.63M | 0.33% | 85 |
|
|
2019
Q4 | – | Sell |
-59,971
| Closed | -$3.54M | – | 390 |
|
|
2019
Q3 | $3.54M | Sell |
59,971
-76,170
| -56% | -$4.49M | 0.14% | 172 |
|
|
2019
Q2 | $8.78M | Sell |
136,141
-15,925
| -10% | -$1.03M | 0.34% | 100 |
|
|
2019
Q1 | $9.66M | Sell |
152,066
-128,114
| -46% | -$8.14M | 0.36% | 88 |
|
|
2018
Q4 | $10.6M | Sell |
280,180
-71,670
| -20% | -$2.72M | 0.45% | 57 |
|
|
2018
Q3 | $15.1M | Sell |
351,850
-103,320
| -23% | -$4.43M | 0.43% | 78 |
|
|
2018
Q2 | $10M | Buy |
+455,170
| New | +$10M | 0.31% | 109 |
|